|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 18 of 21 found articles
| Title: |
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma ☆ |
| Author: |
Horwitz, S. O'Connor, O.A. Pro, B. Trümper, L. Iyer, S. Advani, R. Bartlett, N.L. Christensen, J.H. Morschhauser, F. Domingo-Domenech, E. Rossi, G. Kim, W.S. Feldman, T. Menne, T. Belada, D. Illés, Á. Tobinai, K. Tsukasaki, K. Yeh, S.-P. Shustov, A. Hüttmann, A. Savage, K.J. Yuen, S. Zinzani, P.L. Miao, H. Bunn, V. Fenton, K. Fanale, M. Puhlmann, M. Illidge, T. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 33 () nr. 3 pages 288-298 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
The Authors |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 18 of 21 found articles
| << previous | next >> |